Skip to main content
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2003 Nov;111(15):A804–A805. doi: 10.1289/ehp.111-a804

Toxicogenomic applications to drug risk assessment.

Irwin Y Rosenblum
PMCID: PMC1241750  PMID: 14630518

Full Text

The Full Text of this article is available as a PDF (131.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Goodsaid Federico M. Genomic biomarkers of toxicity. Curr Opin Drug Discov Devel. 2003 Jan;6(1):41–49. [PubMed] [Google Scholar]
  2. Guerreiro Nelson, Staedtler Frank, Grenet Olivier, Kehren Jeanne, Chibout Salah-Dine. Toxicogenomics in drug development. Toxicol Pathol. 2003 Sep-Oct;31(5):471–479. doi: 10.1080/01926230390224656. [DOI] [PubMed] [Google Scholar]
  3. Hamadeh Hisham K., Knight Brian L., Haugen Astrid C., Sieber Stella, Amin Rupesh P., Bushel Pierre R., Stoll Raymond, Blanchard Kerry, Jayadev Supriya, Tennant Raymond W. Methapyrilene toxicity: anchorage of pathologic observations to gene expression alterations. Toxicol Pathol. 2002 Jul-Aug;30(4):470–482. doi: 10.1080/01926230290105712. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES